NM_004044.7:c.-59T>G
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_004044.7(ATIC):c.-59T>G variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.295 in 1,528,280 control chromosomes in the GnomAD database, including 70,884 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.23 ( 5130 hom., cov: 34)
Exomes 𝑓: 0.30 ( 65754 hom. )
Consequence
ATIC
NM_004044.7 5_prime_UTR
NM_004044.7 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.144
Publications
19 publications found
Genes affected
ATIC (HGNC:794): (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase) This gene encodes a bifunctional protein that catalyzes the last two steps of the de novo purine biosynthetic pathway. The N-terminal domain has phosphoribosylaminoimidazolecarboxamide formyltransferase activity, and the C-terminal domain has IMP cyclohydrolase activity. A mutation in this gene results in AICA-ribosiduria. [provided by RefSeq, Sep 2009]
ATIC Gene-Disease associations (from GenCC):
- AICA-ribosiduriaInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 2-215312084-T-G is Benign according to our data. Variant chr2-215312084-T-G is described in ClinVar as [Benign]. Clinvar id is 1192366.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.439 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.233 AC: 35377AN: 152100Hom.: 5126 Cov.: 34 show subpopulations
GnomAD3 genomes
AF:
AC:
35377
AN:
152100
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.302 AC: 415869AN: 1376064Hom.: 65754 Cov.: 33 AF XY: 0.308 AC XY: 209190AN XY: 679094 show subpopulations
GnomAD4 exome
AF:
AC:
415869
AN:
1376064
Hom.:
Cov.:
33
AF XY:
AC XY:
209190
AN XY:
679094
show subpopulations
African (AFR)
AF:
AC:
1375
AN:
30744
American (AMR)
AF:
AC:
10743
AN:
35316
Ashkenazi Jewish (ASJ)
AF:
AC:
7782
AN:
24910
East Asian (EAS)
AF:
AC:
6069
AN:
35208
South Asian (SAS)
AF:
AC:
35934
AN:
78222
European-Finnish (FIN)
AF:
AC:
9517
AN:
34300
Middle Eastern (MID)
AF:
AC:
1301
AN:
4228
European-Non Finnish (NFE)
AF:
AC:
325643
AN:
1075668
Other (OTH)
AF:
AC:
17505
AN:
57468
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
14191
28383
42574
56766
70957
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.233 AC: 35393AN: 152216Hom.: 5130 Cov.: 34 AF XY: 0.235 AC XY: 17469AN XY: 74440 show subpopulations
GnomAD4 genome
AF:
AC:
35393
AN:
152216
Hom.:
Cov.:
34
AF XY:
AC XY:
17469
AN XY:
74440
show subpopulations
African (AFR)
AF:
AC:
2318
AN:
41580
American (AMR)
AF:
AC:
4310
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
AC:
1109
AN:
3472
East Asian (EAS)
AF:
AC:
1137
AN:
5174
South Asian (SAS)
AF:
AC:
2197
AN:
4826
European-Finnish (FIN)
AF:
AC:
2859
AN:
10588
Middle Eastern (MID)
AF:
AC:
93
AN:
294
European-Non Finnish (NFE)
AF:
AC:
20539
AN:
67970
Other (OTH)
AF:
AC:
533
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1368
2736
4103
5471
6839
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1278
AN:
3474
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
AICA-ribosiduria Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.